Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) will raise approximately $7.2 million through a registered direct offering. Shares of the biopharmaceutical dropped 51 cents to $2.45.
Cyclacel To Raise Capital
January 11, 2010 at 12:14 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.